Developing evidence-based immunization recommendations and GRADE

被引:27
作者
Duclos, P. [1 ]
Durrheim, D. N. [2 ]
Reingold, A. L. [3 ]
Bhutta, Z. A. [4 ]
Vannice, K. [5 ]
Rees, H. [6 ]
机构
[1] WHO, CH-1211 Geneva 11, Switzerland
[2] Univ Newcastle, Wallsend, NSW 2287, Australia
[3] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA
[4] Aga Khan Univ, Maternal & Child Hlth Div, Karachi 74800, Pakistan
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA
[6] Wits Inst, Reprod Heath & RIV Res Inst, ZA-2038 Hillbrow, Joahanneburg, South Africa
关键词
Immunization; Evidence-based recommendations; Strategic Advisory Group of Experts on immunization (SAGE); World Health Organization; Grading of Recommendations Assessment; Development and Evaluation (GRADE); QUALITY;
D O I
10.1016/j.vaccine.2012.02.041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Strategic Group of Advisory Experts (SAGE) on immunization is an independent advisory committee with a mandate to advise the World Health Organization (WHO) on the development of vaccine and immunization related policies. SAGE working groups are established on a time-limited basis to review and provide evidence-based recommendations, together with their implications, for open deliberation and decision-making by SAGE. In making its recommendations, SAGE takes into consideration: the epidemiologic and clinical characteristics of the disease; vaccine and immunization characteristics; economic analysis; health system considerations; the existence of and interaction with other intervention and control strategies; costing and social impacts; and legal and ethical concerns. Since 1998, WHO has produced evidence-based vaccine position papers for use primarily by national public health officials and immunization programme managers. Since April 2006 all new or updated position papers have been based on SAGE recommendations. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach has been adopted by WHO and, since 2008, GRADE tables that rate the quality of evidence have been produced in support of key recommendations. SAGE previously expressed concern that GRADE was not ideally suited to many immunization-specific issues such as the vaccine population level effect and the inclusion of surveillance system data, particularly for vaccine safety. Extensive productive interactions with various advisory groups including the US Advisory Committee on Immunization Practices, the European Centres for Disease Control, the German Standing Committee on Vaccination (STIKO), WHO's Global Advisory Committee on Vaccine Safety and the GRADE working group resulted in key enhancements to accommodate vaccine-relevant evidence. This facilitated integration and acceptability of the GRADE approach in the development of immunization related SAGE and WHO recommendations. Ongoing utilisation should result in further fine-tuning of the approach to ensure that recommendations are based on the full range of appropriate evidence. (c) 2012 World Health Organization.. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:12 / 19
页数:8
相关论文
共 13 条
[1]   Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC) [J].
Ahmed, Faruque ;
Temte, Jonathan L. ;
Campos-Outcalt, Doug ;
Schuenemann, Holger J. .
VACCINE, 2011, 29 (49) :9171-9176
[2]  
[Anonymous], 2009, WKLY EPIDEMIOL REC, V84, P533
[3]  
[Anonymous], 2009, COCHRANE HDB SYSTEMA
[4]  
[Anonymous], COCHRANE HDB SYSTEMA
[5]   GRADE guidelines: 3. Rating the quality of evidence [J].
Balshem, Howard ;
Helfand, Mark ;
Schuenemann, Holger J. ;
Oxman, Andrew D. ;
Kunz, Regina ;
Brozek, Jan ;
Vist, Gunn E. ;
Falck-Ytter, Yngve ;
Meerpohl, Joerg ;
Norris, Susan ;
Guyatt, Gordon H. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (04) :401-406
[6]   Establishing global policy recommendations: the role of the Strategic Advisory Group of Experts on immunization [J].
Duclos, Philippe ;
Okwo-Bele, Jean-Marie ;
Salisbury, David .
EXPERT REVIEW OF VACCINES, 2011, 10 (02) :163-173
[7]   GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables [J].
Guyatt, Gordon ;
Oxman, Andrew D. ;
Akl, Elie A. ;
Kunz, Regina ;
Vist, Gunn ;
Brozek, Jan ;
Norris, Susan ;
Falck-Ytter, Yngve ;
Glasziou, Paul ;
deBeer, Hans ;
Jaeschke, Roman ;
Rind, David ;
Meerpohl, Joerg ;
Dahm, Philipp ;
Schuenemann, Holger J. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (04) :383-394
[8]   GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations [J].
Guyatt, Gordon H. ;
Oxman, Andrew D. ;
Vist, Gunn E. ;
Kunz, Regina ;
Falck-Ytter, Yngve ;
Alonso-Coello, Pablo ;
Schuenemann, Holger J. .
BRITISH MEDICAL JOURNAL, 2008, 336 (7650) :924-926
[9]  
Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]
[10]   GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias) [J].
Guyatt, Gordon H. ;
Oxman, Andrew D. ;
Vist, Gunn ;
Kunz, Regina ;
Brozek, Jan ;
Alonso-Coello, Pablo ;
Montori, Victor ;
Akl, Elie A. ;
Djulbegovic, Ben ;
Falck-Ytter, Yngve ;
Norris, Susan L. ;
Williams, John W., Jr. ;
Atkins, David ;
Meerpohl, Joerg ;
Schuenemann, Holger J. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (04) :407-415